relapsed/refractory b-cell lymphomas in the car-t era: improving outcomes in a population at need
Published 2 years ago • 234 plays • Length 50:48Download video MP4
Download video MP3
Similar videos
-
5:22
car-t cell update: therapy improves outcomes for patients with b-cell lymphoma
-
0:48
car t cell options for relapsed/refractory dlbcl
-
5:38
optimizing car t-cell therapy in relapsed/refractory all
-
6:48
car t cell therapy in relapsed/refractory dlbcl
-
4:53
car-t cell therapy vs. bispecific antibody therapies in relapsed lymphoma
-
1:33
management of relapse after car-t in patients with b-cell lymphoma
-
6:37
zuma-7: axi-cel in r/r large b-cell lymphoma
-
1:38
car t-cell therapy appears promising in relapsed/refractory dlbcl
-
4:05
car-t therapy for r/r aggressive b-cell nhl
-
1:11
dr. andreadis on car t-cell therapy in relapsed/refractory mcl
-
3:04
car t-cell therapy for b-cell lymphomas: a focus on improving cr
-
10:30
maximizing b-cell lymphoma outcomes with car t-cell therapy and personalized care
-
5:27
car t-cell therapy: relapsed/refractory all
-
3:08
car t cell axi-cel drives b-cell lymphomas into remission
-
12:46
understanding car t-cell therapy in lymphoma
-
1:43
dr. neelapu on third-line car t-cell therapy in large b-cell lymphoma
-
4:27
cytopenias after axi-cel in r/r large b-cell lymphoma: clinical implications
-
3:21
radiotherapy bridging for axi-cel in large b-cell lymphoma
-
36:37
car t-cell therapy in non-hodgkin lymphoma and multiple myeloma: a clinical update